Grace Therapeutics (GRCE) Q2 2025 Earnings

23JunConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.37
-0.21
-0.05
0.11

Details

Expected EPS
-0.2775
Actual EPS
0.11
Surprise EPS
0.39
Surprise Percent
+139.64%

Description

Grace Therapeutics (GRCE) has reported earnings of 0.11 per share for Q2 2025.

0 Comments

Share your thoughts